These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35784676)

  • 1. Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir.
    Choudhary MC; Cyktor JC; Riddler SA
    J Virus Erad; 2022 Jun; 8(2):100073. PubMed ID: 35784676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
    Ollerton MT; Berger EA; Connick E; Burton GF
    J Virol; 2020 May; 94(10):. PubMed ID: 32161179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering CAR T Cells to Target the HIV Reservoir.
    Mu W; Carrillo MA; Kitchen SG
    Front Cell Infect Microbiol; 2020; 10():410. PubMed ID: 32903563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates.
    Rust BJ; Kean LS; Colonna L; Brandenstein KE; Poole NH; Obenza W; Enstrom MR; Maldini CR; Ellis GI; Fennessey CM; Huang ML; Keele BF; Jerome KR; Riley JL; Kiem HP; Peterson CW
    Blood; 2020 Oct; 136(15):1722-1734. PubMed ID: 32614969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
    Liu D; Tian S; Zhang K; Xiong W; Lubaki NM; Chen Z; Han W
    Protein Cell; 2017 Dec; 8(12):861-877. PubMed ID: 28488245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric antigen receptor T-cell approaches to HIV cure.
    Kuhlmann AS; Peterson CW; Kiem HP
    Curr Opin HIV AIDS; 2018 Sep; 13(5):446-453. PubMed ID: 29878913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Developing CAR T-Cell Therapy for HIV Cure.
    Qi J; Ding C; Jiang X; Gao Y
    Front Immunol; 2020; 11():361. PubMed ID: 32210965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies.
    Keshavarz A; Salehi A; Khosravi S; Shariati Y; Nasrabadi N; Kahrizi MS; Maghsoodi S; Mardi A; Azizi R; Jamali S; Fotovat F
    Stem Cell Res Ther; 2022 Sep; 13(1):482. PubMed ID: 36153626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
    Mylvaganam G; Yanez AG; Maus M; Walker BD
    Front Immunol; 2019; 10():2109. PubMed ID: 31552045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAR T cells: Living HIV drugs.
    Namdari H; Rezaei F; Teymoori-Rad M; Mortezagholi S; Sadeghi A; Akbari A
    Rev Med Virol; 2020 Nov; 30(6):1-14. PubMed ID: 32713110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.
    Mao Y; Zhao C; Zheng P; Zhang X; Xu J
    Immunotherapy; 2021 Feb; 13(2):177-184. PubMed ID: 33225803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.
    Yang H; Wallace Z; Dorrell L
    Front Immunol; 2018; 9():2861. PubMed ID: 30564246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust CAR-T memory formation and function via hematopoietic stem cell delivery.
    Zhen A; Carrillo MA; Mu W; Rezek V; Martin H; Hamid P; Chen ISY; Yang OO; Zack JA; Kitchen SG
    PLoS Pathog; 2021 Apr; 17(4):e1009404. PubMed ID: 33793675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding new lanes: Chimeric antigen receptor (CAR) T-cells for myeloid leukemia.
    Pratap S; Zhao ZJ
    Cancer Rep (Hoboken); 2020 Apr; 3(2):e1222. PubMed ID: 32671999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV.
    Carrillo MA; Zhen A; Zack JA; Kitchen SG
    Transl Res; 2017 Sep; 187():83-92. PubMed ID: 28755872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quarter Century of Anti-HIV CAR T Cells.
    Wagner TA
    Curr HIV/AIDS Rep; 2018 Apr; 15(2):147-154. PubMed ID: 29500712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
    Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
    Front Immunol; 2018; 9():492. PubMed ID: 29616024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects.
    Elahi R; Heidary AH; Hadiloo K; Esmaeilzadeh A
    Stem Cell Rev Rep; 2021 Dec; 17(6):2081-2106. PubMed ID: 34472037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.